Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 11, 2015 9:07:12 AM
It accomplishes nothing as
1) nobody wants to invest in a stock that is worth 20% less by year end....and worth 50% less after 2 years
2) the company can never post a profit when stock grants are accounted for.
3) the company got little flexibility to raise capital at reasonable costs.
4) the company's reputation is very bad because of 1), 2) and 3)
Had the dilution been half of what it is, the employees stock holdings would be worth much more, as the stock price would be $20.
I would rather own 500 stocks worth $20, than 1000 stocks worth $4.
I would rather see Musclepharm taking a sufficient loan or raising capital for financing than executives having to pledge their personal stock holdings. It is all a result of the excessive dilution policy of the company, where more and more stocks are issued for nonsensical purposes that don't create any value whatsoever.
Somebody probably had seen enough of that, and after reading the Bloomberg article, he/she just pulled the trigger.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM